32 results on '"Karikios, Deme"'
Search Results
2. Activin-A, Growth Differentiation Factor-11 and Transforming Growth Factor-β as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer
3. Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians
4. Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines
5. Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study
6. Discussing and prescribing expensive unfunded anticancer drugs in Australia
7. Case series: Immune checkpoint inhibitor-induced transverse myelitis
8. Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers
9. Haematological and nutritional prognostic biomarkers for patients receiving CROSS or FLOT
10. Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia
11. CONSENT - A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials – GBM Cohort (Nonrandomised) Analysis
12. SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response
13. Evaluating Prognostic Factors for Sex Differences in Lung Cancer Survival: Findings From a Large Australian Cohort
14. Opinions and strategies of Australian health professionals on tackling cancer-related financial toxicity : A nationwide survey
15. Metabolic information on staging FDG-PET–CT as a prognostic tool in the evaluation of 97 patients with gastric cancer
16. Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)
17. Additional file 1 of Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines
18. Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic
19. Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
20. Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population
21. Exploring the impact and experience of fractional work in medicine: a qualitative study of medical oncologists in Australia
22. The consequences of rising anticancer drug costs in Australia
23. DREAM – a phase 2 trial of DuRvalumab with first line chEmotherApy in mesothelioma: final result
24. DREAM: A phase II study of durvalumab with first line chemotherapy in mesothelioma-First results
25. Is it all about price? Why requests for government subsidy of anticancer drugs were rejected in Australia
26. A Qualitative Study of Medical Oncologists’ Experiences of Their Profession and Workforce Sustainability
27. Valuing the benefits of new anticancer drugs
28. Rising cost of anticancer drugs in Australia
29. Metabolic information on staging FDG-PET–CT as a prognostic tool in the evaluation of 97 patients with gastric cancer
30. Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
31. Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic
32. Structural racism and inequity in cancer clinical trial participation: time for solutions.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.